These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 8993481)
1. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin. DeKosky ST; Aston CE; Kamboh MI Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481 [TBL] [Abstract][Full Text] [Related]
2. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease. Fallin D; Reading S; Schinka J; Hoyne J; Scibelli P; Gold M; Crawford F; Mullan M Am J Med Genet; 1997 Apr; 74(2):192-4. PubMed ID: 9129722 [TBL] [Abstract][Full Text] [Related]
4. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease. Murphy GM; Sullivan EV; Gallagher-Thompson D; Thompson LW; van Duijn CM; Forno LS; Ellis WG; Jagust WJ; Yesavage J; Tinklenberg JR Neurology; 1997 May; 48(5):1313-6. PubMed ID: 9153464 [TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E and alpha-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Licastro F; Pedrini S; Govoni M; Pession A; Ferri C; Annoni G; Casadei V; Veglia F; Bertolini S; Grimaldi LM Neurosci Lett; 1999 Aug; 270(3):129-32. PubMed ID: 10462111 [TBL] [Abstract][Full Text] [Related]
6. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk]. Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases. Lamb H; Christie J; Singleton AB; Leake A; Perry RH; Ince PG; McKeith IG; Melton LM; Edwardson JA; Morris CM Neurology; 1998 Feb; 50(2):388-91. PubMed ID: 9484359 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and alpha1-antichymotrypsin polymorphism in Alzheimer's disease. Nacmias B; Tedde A; Latorraca S; Piacentini S; Bracco L; Amaducci L; Guarnieri BM; Petruzzi C; Ortenzi L; Sorbi S Ann Neurol; 1996 Oct; 40(4):678-80. PubMed ID: 8871590 [TBL] [Abstract][Full Text] [Related]
9. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease. Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173 [TBL] [Abstract][Full Text] [Related]
10. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease. Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H Neurosci Lett; 1997 Aug; 231(1):56-8. PubMed ID: 9280167 [TBL] [Abstract][Full Text] [Related]
11. Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population. Schwab SG; Bagli M; Papassotiropoulos A; Jessen F; Maier W; Rao ML; Heun R Dement Geriatr Cogn Disord; 1999; 10(6):469-72. PubMed ID: 10559561 [TBL] [Abstract][Full Text] [Related]
12. Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease. Yoshizawa T; Yamakawa-Kobayashi K; Hamaguchi H; Shoji S J Neurol Sci; 1997 Nov; 152(2):136-9. PubMed ID: 9415533 [TBL] [Abstract][Full Text] [Related]
13. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease. Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977 [TBL] [Abstract][Full Text] [Related]
14. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population. Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483 [TBL] [Abstract][Full Text] [Related]
15. Genetic association between susceptibility to Parkinson's disease and alpha1-antichymotrypsin polymorphism. Yamamoto M; Kondo I; Ogawa N; Asanuma M; Yamashita Y; Mizuno Y Brain Res; 1997 Jun; 759(1):153-5. PubMed ID: 9219874 [TBL] [Abstract][Full Text] [Related]
16. Lack of association between alpha 1-antichymotrypsin polymorphism, Alzheimer's disease, and allele epsilon 4 of apolipoprotein E. Müller U; Bödeker RH; Gerundt I; Kurz A Neurology; 1996 Dec; 47(6):1575-7. PubMed ID: 8960749 [TBL] [Abstract][Full Text] [Related]
17. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers. Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and alpha-1-antichymotrypsin genotypes do not predict time to psychosis in Alzheimer's disease. Sweet RA; Kamboh MI; Wisniewski SR; Lopez OL; Klunk WE; Kaufer DI; DeKosky ST J Geriatr Psychiatry Neurol; 2002; 15(1):24-30. PubMed ID: 11936240 [TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E: risk factor for Alzheimer disease. Tsai MS; Tangalos EG; Petersen RC; Smith GE; Schaid DJ; Kokmen E; Ivnik RJ; Thibodeau SN Am J Hum Genet; 1994 Apr; 54(4):643-9. PubMed ID: 8128961 [TBL] [Abstract][Full Text] [Related]